HORMONAL CONTROL OF PITUITARY PROLACTIN-SECRETING TUMORS

Dipak K. Sarkar, Shane T. Hentges, Alok De and Raghaba H.R. Reddy

Department of Veterinary and Comparative Anatomy, Physiology and Pharmacology, Washington State University, Pullman, WA 99163-6540

Received 7/5/98 Accepted 7/15/98

6. REFERENCES

1. M Isibashi & T Yamaji: Functional heterogeneity of human prolactin-producing pituitary adenoma cells. In: Prolactin basic and clinical correlates. Eds: MacLeod R M, Scapagnini U, Thorner M O, Springer-Verlag, NY 641-702 (1985)

2. J Hardy: Ten years after the recognition of pituitary microadenomas. In: Pituitary microadenomas. Eds: Faglia G, Giovanelli M A, MacLeod R M, Academic Press, NY 7-14 (1980)

3. Post, K. D. Jackson, I. M. D. & S. Reichlin: The pituitary adenoma. Plenum Publishing, NY (1980)

4. Furth, J.: Pituitary cybernetics and neoplasia. Harvey Lect 63, 47-71 (1969)

5. Miyai, K. Ichihoza, K. K. Kondo & S. Mori: Asymptomatic hyperprolactinoma in the general population-mass screening by paired assays of serum prolactin. Clin Endocrinol 25, 549- (1986)

6. J Meites: Relation of prolactin to development of spontaneous mammary and pituitary tumors. In: The prostatic cell: structure and function, part b. Alan R Liss, NY 1-8 (1981)

7. J D Neill & G M Nagy: Prolactin secretion and its control. In: The physiology of reproduction. Eds: Knobil E and Neill J D, Raven Press, NY 1834-1860. (1994)

8. Ben-Jonathan, N. Arbogast, L.A. & J.F. Hyde: Neuroendocrine regulation of prolactin release. Prog Neurobiol 33:399-447 (1989)

9. Nicoll C.S.: Endocrinology: physiological actions of prolactin. In: Handbook of Physiology. Eds: Knobil E & Sawyer W.H., Vol 4, Sect 7, American Physiological Society, Washington DC, pp 253-292 (1974)

10. Lesuerur L. Edery, M. S. Ali, J. Paly, P. A. Kelly, & J. Djiane: Comparison of long and short forms of prolactin receptors on prolactin induced milk protein gene transcription. Proc Natl Acad Sci USA 88, 824-828 (1991)

11. Jahn, G.A. Daniel, N. G. Jolivet, L. Belair, C. Bole-Feysot, P.A. Kelly, & J. Dijane: In vivo study of prolactin intracellular signaling during lactogenesis in rat: JAK/STAT pathway is activated by prolactin in the mammary gland but not in the liver. Biol Reprod. 57, 894-900 (1997)

12. W. N. Kelley. Ed: Text Book of Internal Medicine. pp 1983, J.B. Lippincot Co. NY (1996)

13. MacLeod, R. M. Scapagnini, U. & Thorner, M. O.: Pituitary Microadenomas. Academic press, NY 683-855 (1980)

14. Tonner, D. & Schlechte, J.: Contemporary therapy of prolactin-secreting adenomas. Am J Med Sci 306, 395-397 (1993)

15. Van Thiel, D. H.: Feminization of chronic alcoholic men: a formulation. Yale J Biol Med 52, 219-225 (1979)

16. Kim U. K., Clifton, H. & C. Furth: A highly inbred line of wistars rats yielding spontaneousmammo-somatotrophic pituitary and other tumors. J Natl Cancer Inst 24, 1031-1055 (1960)

17. Thompson, S. W. Huseby, R. A. M. A. Fox, C. L. Davis & R. D. Hunt: Spontaneous tumors in the Sprague-Dawley rat. J Natl Cancer Inst 27, 1037-1057 (1961)

18. Kovacs, K. Horvath, E. R. Ilse, G. C. Ezrim & D. R. Ilse: Spontaneous pituitary adenomas in aging rats. A light microscopic, immunocytological and fine structural study. Beitr Pathol 161, 1-16 (1977)

19. Ross, M. H. Bras. G. & M. S. Ragbbeer: Influence of protein and caloric intake upon spontaneous tumor incidence of the anterior pituitary gland of the rat. J Nutr 100, 177-189 (1970)

20. Ross, M. H. & Bras G: Tumor incidence patterns and nutrition in rat. J Nutr 87, 245-260 (1965)

21. Ross, M. H. & Bras, G.: Lasting influence of early caloric restriction on prevalence of neoplasms in the rat. J Natl Cancer Inst 47, 1095-1113 (1971)

22. Sadoul, J. L. Thyss, A. & P. Freychet: Invasive mixed growth hormone/prolactin secreting pituitary tumor: complete shrinking by octreotide withdrawal. Acta Endocrinol 126, 179-183 (1992)

23. Ishibashi, M. & Yamaji, T.: Effects of hypophysiotropic factors on growth hormone and prolactin secretion from somatotroph adenomas in culture. J Clin Endocrinol Metab 60, 985-988 (1985)

24. DeNicola, A. F. Von Lawzewifsch, I. S. E. Kaplan & C. Libertum: Biochemical and ultrastructural studies of estrogen-induced pituitary tumors in F344 rats. J Natl Cancer Inst 61, 753-763 (1978)

25. Wickland, S.A. Werts, N. & J. Gorski: A comparison of estrogen effect on uterine and pituitary growth and prolactin synthesis in F-344 and Holtzman rats. Endocrinology 109, 1700-07 (1981)

26. Sarkar, D.K Gottschall, P.E & J. Meites: Relation of the neuroendocrine system to development of prolactin secretion pituitary tumors. In: Neuroendocrinology of Aging. Ed: Meites J., Plenum Press, New York, pp 353-376 (1983)

27. Sarkar, D. K. Gottschall, P. E. & J. Meites: Damage to hypothalamic dopaminergic neurons is associated with development of prolactin-secreting tumors. Science 218, 684-686 (1982)

28. Banerjee, S.K. De, A.& D.K.Sarkar: Colocalization of prolactin and PCNA within anterior pituitary cells in estrogen treated rats: Evidence for the induction of lactotrope cell proliferation during estrogen induced pituitary tumors. Cancer Letter 83, 139-14 (1994)

29. Shull, J. D. Spady, T. J. M. C. Snyder, S. L. Johansson & K. L. Pennington: Ovary-intact, but not ovariectomized female ACI rats treated with 17-fl estradiol rapidly develop mammary cacinoma. Carcinogenesis 18, 1595-1602 (1997)

30. Lloyd, R. V.: Estrogen-induced hyperplasia and neoplasia in the rat anterior pituitary gland. Am J Pathol 113, 198-206 (1983)

31. Gooren, L. Assies, J. G. J. Asscheman, A. R. deSlegte & H. vanKessel: Estrogen-induced prolactinoma in a man. J Clin Endocrinol Metab 66, 444-446 (1987)

32. Prior, J. C., Cox, T. A. D. Fairholm, E. Kostashuk & R. Nugent: Testerone-related exacerbation of a prolactin-producing macroadenoma: possible role for estrogen. J Clin Endocrinol Metab 64, 391-394 (1987)

33. Garcia, M. M. & Kapcala, L. P.: Growth of a microprolactinoma to a macroprolactinoma during estrogen therapy. J Endocrinol Invest 18, 450-455 (1995)

34. Carol, W. Lauterbach, H. G. Klinger, A. Unger & W. Michels: Prolactin stimulation using the metoclopramide test in females taking oral contraceptives. Zentralbl Gynakol 110, 1515-1521 (1988)

35. Shy, K. K. McTiernan, A. M. J. R. Daling & N. S. Weiss: Oral contraceptives use and the occurrence of pituitary prolactinoma. J Am Med Assoc 249, 2204-2207 (1983)

36. Luciano, A. A. Sherman, B. M. F. K. Chapler, K. S. Hauser & R. B. Wallace: Hyperprolactnemia and contraception: a prospective study. Obstet Gynecol 65, 506-510 (1985)

37. Holmgren, U. Bergstrand, G. K. Hagenfeldt & S. Werner: Women with prolactinoma-effect of pregnancy and lactation on serum prolactin and on tumor growth. Acta Endocrinol (Copenh) 111, 452-459 (1986)

38. Gíomez, F. Reyes, F. & C. Fairman: Nonpuerperal galactorrhea and hyperprolactinemia. Clinical findings, endocrine features and therapeutic responses in 56 cases. Am J Med 62, 648-660 (1977)

39. Sherman, B. M. Schlechte, J. N. S. Halmi, F. K. Chapler, C. E. Harris, T. M. Duello, J. VanGilder & D. K. Granner: Pathogenesis of prolactin-secreting pituitary adenomas. Lancet 11, 1019-1021 (1978)

40. Chang, R. J. Keye, W. R. J. R. Young, C. B. Willson & R. B. Jaffe: Detection, evaluation and treatment of pituitary microadenomas in patients with galactorrhea and amenorrhea. 128, 356-363 (1977)

41. S K Teoh N K Mello & J H Mendelson: The effect of alcohol abuse on the menstrual cycle. In: Reproductive neuroendocrinology of aging and drug abuse. Eds: Sarkar D K, Barnes C D, CRC Press, FL, 335-364 (1994)

42. J S Gavaler: Aging alcohol: the hormonal status of postmenopausal women. In: Reproductive neuroendocrinology of aging and drug abuse. Eds: Sarkar D K, Barnes C D, CRC Press, FL, 365-378 (1994)

43. Rosenblum, E. R. Van Thiel, D. H. & I. M. Campbell: Separation and identification of phyto-estrogenic compounds isolated from bourbon. Alcohol Alcohol Suppl 1, 551-555 (1987)

44. Rosenblum, E. R. Van Thiel, D. H. I. M. Campbell & J. S. Gavaler: Quantitation of ß-sitosterol in bourbon. Alcohol Clin Exp Res 15, 205-206 (1991)

45. Gavaler, J. S. Rosenblum, E. R. & D. H. Van Thiel: Biologically active phyto-oestrogens are present in bourbon. Alcohol Clin Exp Res 11, 399-405 (1987)

46. Gavaler, J. S. Van Thiel, D. H. & A. Galvao-Teles: Oestrogenic responses in normal postmenopausal women to administration of the phytoestrogens in bourbon whisky. Hepatology 14, 87-89 (1991)

47. Rosenblum, E. R. Campbell, I. M. D. H. Van Thiel & J. S. Gavaler: Isolation and identification of phytoestrogens from beer. Alcohol Clin Exp Res 16, 843-845 (1992)

48. Price, K. R. & Fenwick, C. R.: Naturally occurring oestrogens in foods-- A review. Food Addit Contam 2, 73-106 (1985)

49. Bickoff, E. R. Livingston, A. L. A. P. Hendrickson & A Booth: Relative potencies of several estrogen-like compounds found in forages. J Agric Food Chem 10, 410-412 (1962)

50. Shutt, D. A. & Cox, R. I.: Steroid and phyto-oestrogen binding to sheep uterine receptors in vitro. J Endocrinol 52, 299-310 (1972)

51. Verdeal, K. Brown, R. R. T. Richardson & D. S. Ryan: Affinity of phytooestrogens for estradiol-binding proteins and effect of coumestrol on growth of 7, 12-dimethylbenz(a) anthracene-induced rat mammary tumors. J Natl Cancer Inst 64, 285-290 (1980)

52. Valimaki, M. Pelkonen, R. M. Harkonen, P. Tuomala, P. Koistinen, R. Roine & R. Ylikahri: Pituitary gonadal hormones and adrenal androgens in non-cirrhotic female alcoholics after cessation of alcohol intake. Eur J Clin Invest 20, 177 (1990)

53. Seki M. Yoshida, K. & Y. Okamura: A study of hyperprolactinemia in female patients with alcoholics. Jpn J Alcohol Drug Depend 26, 49 (1991)

54. Seki, M. Yoshida, K. & Y. Okamura: Hormones in amenorrheic women with alcoholics. Jpn J Fertil Steril 36, 630 (1991)

55. Teoh, S. K. Lex, B. W. J. H. Mendelson, N. K. Mello & J. Cochin: Hyperprolactinemia and macrocytosis in women with alcohol and polysubstance dependence. J Stud Alcohol 53, 176 (1992)

56. Mendelson, J. H. & Mello, N. K.: Chronic alcohol effects on anterior pituitary and ovarian hormones in healthy women. J Pharmacol Exp Ther 245, 407 (1988)

57. Marchesi, C. De Risio, C. G. Campanini, C. Majgini, P. Piazza, M. Grassi, P. Chiodera & V. Criro: TRH test in alcoholics: relationship of the endocrine results with neuroendocrinological and neuropsychological findings. Alcohol Alcohol 27, 531-537 (1992)

58. Ida, Y. Isujimararu, S. K. Nakamura, I. Shirrao, H. Mukasa, H. Egami & Y. Nakazawa: Effects of acute and repeated alcohol ingestion on hypothalamic-pituitary gonadal and adrenal functions in normal males. Drug Alcohol Depend 31, 57-64 (1992)

59. Soyka, M. Gorig E. & D. Naber: Serum prolactin increase induced by ethanol - a dose dependent effect not related to stress. Psychoneuroendocrinology 16, 441-446 (1991)

60. Mello, N. K. Bree, M. P. J. H. Mendelson, J. N. Ellingboe, W. King & P. K. Sehgai: Alcohol self-administration disrupts reproductive function in female macaque monkeys. Science 221, 677 (1983)

61. Mello, N. K. Mendelson, J. H. M. P. Bree & A. Skupny: Alcohol effects on Naloxone-stimulated luteinizing hormone, follicle-stimulating hormone and prolactin plasma levels in female rhesus monkeys. J Pharmacol Exp Ther 245, 895-904 (1988)

62. Koret, M. Goosen, C. J. H. Thyssen & J. M. Van Ree: Endocrine profile during acquisition of free-choice alcohol drinking in rhesus monkeys: treatment with desglycinamide-(Arg 8)-vasopressin. Alcohol Alcohol 27, 403-410 (1992)

63. Sanchis, R. Esquifino, A. & C. Guerri: Chronic ethanol intake modifies estrous cyclicity and alters prolactin and LH levels. Phamacol Biochem Behav 23, 221-224 (1985)

64. Purohit, V.: Effect of alcohol on the hypothalamic pituitary-gonadal axis. In National institute on alcohol abuse and alcoholism, alcohol and the endocrine system: research monograph 23, No. 93-3533. NIH publication, Washington, D. C. 189-205 (1993)

65. De, A. Boyadjieva, N. M. Pastorcic & D. K. Sarkar: Potentiation of the mitogenic effect of estrogen on the pituitary gland by alcohol consumption. Int J Oncol 7, 643-648 (1995)

66. Stone R.: Environmental estrogens stir debate. Science 265: 308-310 (1994)

67. Hunter, D.J., & Kelsey, K.T. Pesticide residues and breast cancer:the harvest of silent spring. J Natl Cancer Inst 85, 598-599 (1993)

68. Colborn, T., Von Saal F.S.& A.M. Soto: Developmental effects of endocrine-disrupting chemicals in wildlife and effects of endocrine-disrupting chemicals in wildlife and humans. Environ Health Perspect 101: 378-84 (1993)

69. Sharpe R.M.& Shakkeback N.E.: Are estrogens involved in failing sperm counts and disorders of the male reproductive tract? Lancet 341, 1392-5 (1993)

70. Dees, C., Asakari, M., J.S. Foster, S. Ahamed & J Wimalasena: DDT mimicks estradiol stimulation of breast cancer cells to enter cell cycle. Mol Carcinogenesis 18: 107-114 (1997)

71. Krishnan, A.V., Stathis, P., S.F. Permuth, L. Tokes & D. Feldman. Bisphenol A: an estrogenic substance released from polycarbonate flask during autoclaving. Endocrinology 132: 2279-2286 (1993)

72. Steinmetz R., Brown N.G., D.L. Allen, R.M., Bigsby & N. Ben-Jonathan.: The environmental estrogen bisphenol A stimulates prolactin release in vitro and in vivo. 1997. Endocrinology 138, 1780-1786 (1977)

73. Hunter, D.J., Hankinson, S.E., F. Laden. Plasma organochlorine levels and the risk of breast cancer. N Engl J Med 337, 1253-1258 (1997)

74. Feldman, D: Estrogen from plastic-are we being exposed? Endocrinology 138: 1777-1779 (1997)

75. Dickson, R. R. & Lippman, M. E.: Estrogen regulation of growth and polypeptide growth factor secretion in human breast carcinoma. Endocr Rev 8, 29-43 (1987)

76. Sirbasku, D.A.: Estrogen induction of growth factors specific for hormone-responsive mammary, pituitary and kidney tumor cells. Proc Natl Acad Sci U.S.A. 75, 3786-90 (1978)

77. Li, J.J. Gonzalez, A. S. Banerjee, S. K. Banerjee & S. A. Li: Estrogen carcinogenesis in the hamster kidney: role of cytotoxicity and cell proliferation. Environ Health Perspect 101, 259-64 (1993)

78. Li, J.J.: Perspectives in hormonal carcinogenesis: animal models to human disease. Prog Clin Biol Res 34, 447-54 (1996)

79. Clark, R. Skaar, T. K. Baumann, F. Leonessa, M. James, J. Lippman, E. W. Thompson, C. Freter & N. Brunner: Hormonal carcinogenenesis in breast cancer: cellular and molecular studies of malignant progression. Breast Cancer Res Treat 31, 237-248 (1994)

80. Newbold, R. R. Bullock, B .C. & J. A. McLachlan: Uterine adonocarcinoma in mice following developmental treatment with estrogens: a model for hormonal carcinogenesis. Cancer Res 50, 7677-81 (1990)

81. Ashburn, S. P. Han, X. & J. G. Liehr: Microsomal hydroxylation of 2-and 4-fluoroestradiol to catechol metabolites and their conversion to methyl ethers: catechol estrogens as possible mediators of hormonal carcinogenesis. Mol Pharmacol 43, 534-41 (1993)

82. Russfield, A.B.: Tumors of endocrine glands and secondary sex organs. U.S. Dept. of health, education, and welfare, Public Health Services, Washington, D.C., U.S. government printing office (1966)

83. Green, S. Walter, P. V. Kumar, J. M. Bornert, P. Argos & P. Chambon: Human oestrogen receptor CDNA: sequence, expression and homology to V-erb-A. Nature 320, 134-39 (1989)

84. Demay, F. Tiffoche, C & M. L. Thieulant: Sex-and cell-specific expression of an estrogen receptor isoform in the pituitary gland. Neuroendocrinology 63(6), 522-9 (1996)

85. B S Katzenellenbogen J Gorski: Estrogen actions on synthesis of macromolecules in target cells. In: Biochemical actions of hormones. Vol. III Ed: Litwack L, Academic Press, NY (1975)

86. N Weigel: Steroid receptors and their regulation by phosphorylation. In: Protooncogenes and growth factors in steroid hormone induced growth and differentiation. Eds: Khan S, Stancel G, CRC Press, FL (1994)

87. King, W. J. & Green, G. L.: Monoclonal antibodies localize oestrogen receptor in the nuclei of target cells. Nature 307,47 (1984)

88. Gorski, J. & Gannon, F.: Current models of steroid hormone action : a critique. Ann Rev Physiol 38, 425-50 (1976)

89. Bocquel, M.T. Kumar, V. C. Stricker, P. Chanbon & H. Gronemeyer : The contribution of the N-C-terminal regions of steroid receptors to activation of transcription is both receptor and cell specific. Nucleic Acids Res 17, 2581 (1989)

90. J Landers & T Spelsberg: In: Critical reviews in eukaryotic gene expression. Eds: Stein G, Stein J & Lion J, CRC Press, FL (1992)

91. Beck, C. A. Weigel, N. L & D. P. Edwards: Effects of hormone and cellular modulators of protein phosphorylation on transcriptional activity, DNA binding, and phosphorylation of human progesterone receptors. Mol. Endocrinol 6, 607-610 (1992)

92. Aronica, S. M. & Katzenellen, B. S.: Progesterone receptor regulation in uterine cells: Stimulation by estrogen, cyclic adenosine 3 ,5-monophosphate, and insulin-like growth factor I and suppression by antiestrogens and protein kinase inhibitors. Endocrinology 128, 2045 (1991)

93. Lingnam, R. B. Stancel, G. M. & D. S. Loose-Mitchell: Estrogen regulation of epidermal growth factor receptor messenger ribonucleic acid. Mol Endocrinol 2, 230 (1988)

94. DiAugustine, R. P. Petrusz, P. G. I. Bell, C. F. Brown, K. S. Korach, J. A. McLachlan & C. T. Teng: Influence of estrogens on mouse uterine epidermal growth factor precursor protein and messenger ribonucleic acid. Endocrinology 122, 2355-61 (1988)

95. Denner, L. A. Weisel, N. L. B. L. Maxwell, W. T. Schrader & B. W. O’Malley: Regulation of progesterone receptor-mediated transcription by phosphorylation. Science 250, 1740 (1990)

96. Stancel G.M, H Boettger-Tong, S M Hyder, J L Kirkland & D S Loose-Mitchell: Uterine c-fos: A paradigm for control of gene expression during estrogen stimulated target tissue growth. In: Protooncogenes and growth factors in steroid hormone induced growth and differentiation. Eds: Khan S, Stancel, G, CRC Press, FL. (1994)

97. Day, R.N. Koike, S. M. Muramatsu & R.A. Maurer: Both Pit-1 and the estrogen receptor are required for estrogen responsiveness of the rat prolactin gene. Mol Endocrinol 4, 1964-71 (1990)

98. Tiboldi, T., Virach, S. K. Kovacs, M. Hode & M. Julesz: Electron microscopic studies of estrogen-induced adenomata developing in intercellular and transplanted rat anterior pituitaries. J. Microsc 6, 677 (1967)

99. Ying, C. Gregg, D. W. & J. Gorski: Estrogen-induced changes in r RNA accumulation and RNA polymerase I activity in the rat pituitary: correlation with tumor susceptibility. Mol Cell Endocrinol 118, 207-13 (1996)

100. Schechter, J. E., Pattison, A. & T. Pattison: Development of the vasculature of the anterior pituitary: ontogeny of basic fibroblast growth factor. Dev Dyn 197, 81-93 (1993)

101. Goustin, A.S. Leof, E. B. G.D. Shipley & H.L. Moses: Growth factors and cancer. Cancer Res 46,1015 (1986)

102. Helden, C.H. & Westermard, B.: Growth factors: mechanism of action and related oncogenes. Cell 37, 9 (1984)

103. Clark, B. F.: The effect of oestrogen and progesterone on uterine cell division and epithelial morphology in spayed, adrenalectomized rats. J Endocrinol 50, 527 (1971)

104. Parrot, J.A. Vigne, J.L.B.Z.Chu & M.K. Skinner: Mesenchymal-epithelial interactions in the ovaries follicle involve keratinocyte and hepatocytes growth factor production by theca cells and their action on grannular cells. Endocrinology 135:569-575 (1994)

105. R.M. Bigsby, R.M. Li, A.& Everett L.: Stromal-epithelial interactions regulating cell proliferation in the uterus. In: Local System in Reproduction. Eds: Magness R.R. & Naftolin F, Raven Press, New York, pp 171-188 (1993)

106. Borgundvaug, B. Kudlow, J.E. S.G. Muller & S.R. George: Dopamine receptor activation inhibits estrogen stimulated transforming growth factor-a gene expression and growth in anterior pituitary, but not in uterus. Endocrinology 130:3453-8 (1992)

107. Korbin, M.S. Asa S.L.J. Samsoondar & J.E. Kudlow: a-Transforming growth factor in the bovine anterior pituitary gland: secretion by dispersed cells and immunohistochemical localization. Endocrinology 121:1412-1415 (1987)

108. McAndrew, J. Paterson A. J. S. L. Asa K.J. McCarthy & J.E. Kudlow: Targeting of transforming growth factor-alpha expression to pituitary lactotropes in transgenic mice results in selective lactotrope proliferation and adenomas. Endocrinology 136, 4479 (1995)

109. Vanderburg, B. deGroot, R. P. L. Isbrucker, W. Kruiger & S. Deloat: Stimulation of TPA-response element activity by a cooperative action of insulin and estrogen in human breast cancer cells. Mol Endocrinol 4, 1720 (1990)

110. Newton, C.J. Buric, R. T. Trapp, S. Brockmeier, W. Pagotto & G.K. Stalla: The unliganded estrogen receptor (ER) transduces growth factor signals. J Steroid Biochem Mol Biol 48 (5-6), 481-6 (1994)

111. Schechter, J. & Weiner, R.: Changes in basic fibroblast growth factor coincident with estradiol-induced hyperplasia of the anterior pituitaries of Fischer 344 and Sprauge-Dawley rats. Endocrinology 129, 2400-2408 (1991)

112. Takahashi, H. & Nakagawa, S.: Effects of estrogen on cell growth factor receptor induction in MET/Se cells. Endocr Res 23 (1-2), 95-104 (1997)

113. Shimon, I. Huttner, A. J. Said, O.M. Spirina & S. Melmed: Heparin-binding secretory transforming gene (hst) facilitates rat lactotrope cell tumorigenesis and induces prolactin gene transcription. J Clin Invest 97(1), 187-95 (1996)

114. Newton, C. J. Artz, E. & G.K. Stalla: Involvement of the estrogen receptor in the growth response of pituitary tumor cells to interleukin-2. Biochem Biophys Res Commun 205 (30), 1930-7 (1994)

115. Missale, C. Losa, M. S. Sigala, A. Balsari, M. Giovanelli & P.F. Spano: Nerve growth factor controls proliferation and progression of human prolactinoma cell lines through an autocrine mechanism. Mol Endocrinol 10, 272-85 (1996)

116. Missale, C. Sigala, S. C. Fiorentine, A. Finarcle, M. Losa, M. Giovanelli & P. Spano: Nerve growth factor suppresses the tumoral phenotype of human prolactinomas. Horm Res 47, 240-4 (1997)

117. Missale, C., Boroni, F., M. Losa, M. Giovanelli, A. Zanellato, R. Dal-loso, A Balsari & P. Spano: Nerve growth factor suppresses the transforming phenotype of human prolactinomas. Proc Natl Acad Sci USA, 90, 7961-5, (1993)

118. Massagué J: Receptors for the TGF-ß family. Cell 69:1067 (1992)

119. Moses, H.L., Young E.Y. & J.A. Pietenpol: Regulation of epithelial proliferation by TGF-beta. Cell 63, 245-247 (1990)

120. Sporn, M.B., Roberts, A. B. L.M. Wakerfield & R.KJ. Assoion: Transforming growth factor-beta; biological function and chemical structure. Science 233, 532-4 (1986)

121. Moses, H.L., Young E.Y. & J.A. Pietenpol: Regulation of epithelial proliferation by TGF-beta. Ciba Foundation Symp. 157, 44-74 (1991)

122. Ignoz, R.A. & Massague, J.: Transforming growth factor stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J Biol Chem 261,4337-45 (1986)

123. Geiser, A.G., Burmester, J.K. R. Webbink, A.B. Robert & A.B. Sporn: Inhibition of growth factor-beta following fusion of two nonresponsive human carcinoma lines. Implication of the type II receptor in growth responses. J Biol Chem 267, 2588-93 (1992)

124. Sarkar, D.K. Kim, K.H.& S.Minami S.: Transforming growth factor-ß1 mRNA and protein expression in the pituitary gland and its action on PRL secretion and lactotropic growth. Mol Endo 6, 1825-1833 (1992)

125. Burns, G.& Sarkar, D.K. 1993. Transforming growth factor-ß1-like immunoreactivity in the pituitary gland of the rat: effect of estrogen. Endocrinology 133, 1444-1449 (1993)

126. Minami, S. & Sarkar, D.K.:Transforming growth factor-ß1 inhibits prolactin secretion and lactotropic cell proliferation in the pituitary of estrogen-treated Fischer 344 rats. Neurochem Intl 499-506 (1997)

127. De, A. Morgan T.E.R.C. Speth, N. Boyadjieva, M. Pastorcic & D.K.Sarkar: Pituitary lactotrope expresses TGF-ß type II receptor mRNA and protein and contains [125I]TGF-ß1-binding sites. J Endocrinol 149, 19-27 (1996)

128. Pastorcic, M. De, A.N. Boyadjieva, W. Vale & D.K.Sarkar: Reduction in the expression and action of transforming growth factor ß1 on lactotropes during estrogen-induced tumorigenesis. Cancer Research 55, 4892-4898 (1995)

129. Pastorcic, M. & Sarkar, D.K.: Down regulation of TGF-ß1 gene expression in anterior pituitary cells treated with forskolin. Cytokine 9, 106-111 (1997)

130. Piroli, G.Weisenberg, L.S. C. Grillo & A.F. De Nicola: Subcellular distribution of cyclic adenosine 3', 5'-monophosphate-binding protein and estrogen receptors in control pituitaries and estrogen-induced pituitary tumors. J Natl Cancer Inst, 82, 596 - 601 (1990)

131. Raghavan, R. Harrison, D. P. G. Ince, M. Daniels, P. Birch, G.I. Caldwell & P. Kendall-Taylor: Oncoprotein immunoreactivity in human pituitary tumors. Clinical Endocrinology, 40, 117 - 126 (1994)

132. Pei, L. Melmed, S. B Scheithauer, K. Kovacs & D. Prager: H-ras mutations in human pituitary carcinoma metastases. J Clin Endo Metab, 78, 842-846 (1994)

133. Cryns, V.L. Alexander, J.M. A Klibanski & A Arnold. The retinoblastoma gene in human pituitary tumors. J Clin Endo Metab, 77, 644-646 (1993)